a year ago
Briefly Bio Secures $1.2m to Enhance Reproducibility in Lab Work
Briefly Bio, a London-based biotech startup, has raised $1.2m in pre-seed funding led by Compound VC to expand its operations and development efforts.
ProblemTechnology
"Making lab work reproducible is a major problem in the scientific community. Over 50% of attempts to reproduce experiments fail, costing the industry over $50bn each year. This is because scientists struggle to reproduce and build on each other’s experiments, and data scientists lack the necessary context to analyze the data produced in labs."
Solution
"Briefly Bio has developed AI-powered software that converts existing experiment descriptions into a consistent format, making them understandable to any new scientist. The software also automatically fills in gaps and spots errors, capturing the value of every experiment and enabling scientists to learn from each other’s work."
